tiprankstipranks
Sunshine Biopharma announces Nora Pharma launch of two new generic drugs
The Fly

Sunshine Biopharma announces Nora Pharma launch of two new generic drugs

Sunshine Biopharma announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs. The first product is Varenicline, a generic version of Champix. Varenicline is used as a smoking cessation product and is available in formats of 0.5 mg and 1 mg tablets, as well as a starter kit. The second is Betahistine, a generic version of Serc, to treat patients with vertigo. Betahistine is available in formats of 8 mg, 16 mg and 24 mg scored tablets. “Propelled by Sunshine Biopharma’s strategic support, Nora Pharma plans to continue its rapid top-line and bottom-line growth,” said Malek Chamoun, president of Nora Pharma.

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App